<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335433">
  <stage>Registered</stage>
  <submitdate>30/04/2010</submitdate>
  <approvaldate>6/05/2010</approvaldate>
  <actrnumber>ACTRN12610000362099</actrnumber>
  <trial_identification>
    <studytitle>Postoperative sleep disturbances and quality of sleep after Remifentanil or Fentanyl based anaesthesia</studytitle>
    <scientifictitle>Postoperative sleep disturbances and quality of sleep after Remifentanil or Fentanyl based anaesthesia in patients undergoing elective surgery</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Long-term postoperative sleep disturbances</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients receive remifentanil-based anaesthesia during their elective operation. This is a one off treatment. Remifentanil is continuously infused intravenously at a rate of 0.15 - 0.3 mcg/kg/min. The infusion starts on induction of anaesthesia and finishes after the surgical procedure before emergence. Approximate duration of anaesthesia is between 45 and 120 minutes.</interventions>
    <comparator>Patients receive fentanyl-based anaesthesia during their elective operation. For induction of anaesthesia, patients receive 0.5 - 1.5 mcg / kg fentanyl for induction of anaesthesia. During the procedure, repetitive doses of 0.5 - 1 mcg / kg, as clinically appropiate. Duration of anaesthesia is between 45 and 120 minutes.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Changes in postoperative quality of sleep 3 months postoperatively are assessed using the Pittsburgh Sleep Quality Quality Index (PSQI).</outcome>
      <timepoint>3 months postoperatively</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in postoperative quality of sleep 6 months postoperatively are assessed using the Pittsburgh Sleep Quality Quality Index (PSQI).</outcome>
      <timepoint>6 months postoperatively</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Surgery under general anaesthesia
Perioperative Anaesthesia Risk Status according to American Association of Anesthesiology (ASA) I-III 
Estimated anaesthesia time &gt; 60 minutes</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Age&lt; 18, Head Injury, Cardiac Surgery, Alcohol addiction, Other drug addictions, ASA &gt; III, incapacity to consent, medication with drugs known to potentially interact with sleep quality (e.g. benzodiazepines, ketamine, beta-receptor-blockers), previous and continueing use of opioids.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Identified from theatre list. Written informed consent as per ethical guidelines. Allocation concealment by sealed opaque envelopes. Patients blinded to intervention</concealment>
    <sequence>Randon number generator using computerized sequence generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>7/05/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Manuel Wenk</primarysponsorname>
    <primarysponsoraddress>Royal Perth Hospital
Wellington Street Campus
Perth 6000
WA</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Manuel Wenk</fundingname>
      <fundingaddress>Royal Perth Hospital
Wellington Street Campus
Perth 6000
WA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Modern anaesthesia incorporates the use of short-acting opioids such as remifentanil. Lately, there has been emerging evidence in the literature that some opioids might influence postoperative sleep quality for up to many months. We aim to compare sleep quality after exposure to 2 opioids regularly used in the clinical routine at Royal Perth Hospital.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Perth Ethics Committee</ethicname>
      <ethicaddress>Royal Perth Hospital
Wellington Street Campus
Perth 6000
WA</ethicaddress>
      <ethicapprovaldate>23/04/2010</ethicapprovaldate>
      <hrec>EC 2010/019</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Manuel Wenk</name>
      <address>Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street Campus
Perth 6000
WA</address>
      <phone>+ 61 8 93841036</phone>
      <fax />
      <email>manuel.wenk@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Manuel Wenk</name>
      <address>Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street Campus
Perth 6000
WA</address>
      <phone>+ 61 8 93841036</phone>
      <fax />
      <email>manuel.wenk@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address>Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street Campus
Perth 6000
WA</address>
      <phone />
      <fax />
      <email />
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>